Literature DB >> 6176251

In vitro monocyte maturation in squamous-cell carcinoma of the lung: influence of humoral factors.

R G Dent, P J Cole.   

Abstract

A previously described defect of in vitro monocyte maturation in patients with squamous-cell carcinoma of the lung (SCC) has been investigated further. The maturation of patients' monocytes in pooled normal human serum was significantly better than in autologous serum. Conversely, the maturation of normal control monocytes was significantly depressed in patients' serum. The defect has been shown to be due to the presence of an inhibitory factor, rather than the lack of a necessary component in the patients' serum. Artificially aggregated gamma-globulin inhibited monocyte maturation in vitro, but the presence of immune complexes in the serum of many patients with SCC did not correlate well with the depression of in vitro maturation of monocytes from the same patient. Similarly, pregnancy-associated alpha 2-glycoprotein, in increased amounts in the serum of patients with SCC, showed no correlation with monocyte maturation. The addition of soluble extracts of tumour, but not of surrounding normal lung tissue significantly inhibited monocyte maturation. The results suggest that the defective monocyte maturation in patients with SCC is at least in part due to serum inhibitory factors, which are likely to be a heterogeneous group.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6176251      PMCID: PMC2010983          DOI: 10.1038/bjc.1982.88

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  32 in total

1.  Detection of antibodies and soluble antigen-antibody complexes by precipitation with polyethylene glycol.

Authors:  W D Creighton; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

2.  Abnormal monocyte chemotactic response in cancer patients.

Authors:  D A Boetcher; E J Leonard
Journal:  J Natl Cancer Inst       Date:  1974-04       Impact factor: 13.506

3.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

4.  Dimensions of humoral recognition factor depletion in carcinomatous patients.

Authors:  J C Pisano; J P Jackson; N R Di Luzio; H Ichinose
Journal:  Cancer Res       Date:  1972-01       Impact factor: 12.701

5.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

6.  Serum factors causing impaired macrophage function in systemic lupus erythematosus.

Authors:  B O Svensson
Journal:  Scand J Immunol       Date:  1975       Impact factor: 3.487

7.  Defective monocyte function in patients with genitourinary carcinoma.

Authors:  M S Hausman; S Brosman; R Snyderman; M R Mickey; J Fahey
Journal:  J Natl Cancer Inst       Date:  1975-11       Impact factor: 13.506

8.  Antileukotactic properties of tumor cells.

Authors:  J P Brozna; P A Ward
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

9.  Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection.

Authors:  R J North; D P Kirstein; R L Tuttle
Journal:  J Exp Med       Date:  1976-03-01       Impact factor: 14.307

10.  Antiinflammatory effects of murine malignant cells.

Authors:  R M Fauve; B Hevin; H Jacob; J A Gaillard; F Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

View more
  1 in total

1.  Further studies on the differences in cytotoxicity of human peripheral blood monocytes and bronchoalveolar macrophages for cultured human lung cells.

Authors:  S Swinburne; M Moore; P Cole
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.